Does concomitant prolactin measurement ıncrease the accuracy of ınferior petrosal sinus sampling?
Abstract
Introduction Prolactin (PRL) measurement during inferior petrosal sinus sampling (IPSS) can be helpful to improve the accuracy. We aimed to evaluate the effect of measuring PRL levels as a predictor for the accuracy of IPSS and evaluate its impact on the lateralization of adenomas. Methods In this retrospective cohort study, we reviewed 51 patients who had undergone IPSS for the investigation of ACTH-dependent hypercortisolism. Results Forty-nine patients had proven Cushing's disease (CD), one had EAS, and the remaining one patient had adrenal adenoma. Forty-seven patients had an above 2 ACTH IPS/P ratio at baseline, and all the post-corticotropin-releasing hormone (CRH) ACTH IPS/P ratios of patients with proven CD were above 3. In these two patients whose ACTH IPS/P ratio at baseline was below 2, PRL IPS/P ratios were above 1.8 in only the dominant side, which was considered secondary to a prolactin intersinus gradient due to the biological effects of the tumor. PRL-adjusted ACTH IPS/P ratios were > 1.3 in all patients with proven CD; it was 0.7 in the patient with EAS. Surgically confirmed positive lateralization was observed in 55.1% of patients with the ACTH gradient, but when PRL-adjusted ACTH IPS/IPS ratios were used in addition to the ACTH gradient, the ratio increased to 67.3%. Conclusion Although PRL-adjusted ACTH IPS/P ratios can be helpful to improve the accuracy of results during IPSS procedures, a prolactin intersinus gradient towards the ACTH-dominant side in patients with CD may invalidate PRL as an indicator of pituitary venous outflow.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Prolactin-adjusted intersinus ACTH ratios can be used for tumor lateralization.
“Studies have also shown how prolactin-adjusted intersinus ACTH ratios can be used for tumor lateralization (77, 79).”
From Approach to the Patient: Diagnosis of Cushing Syndrome (2022) · cites this paper as [79]
No citation lists for this paper
No citation lists for this paper yet — checked again daily.
References 36 · Cited by 6
- Authors
- Apaydin, T., Yasar, M., Baltacioglu, F., Haklar, G., & Gogas Yavuz, D.
- Affiliations
- Marmara University (TR)
- Venue
- Neuroradiology
- Published
- 2022-01-22
- Volume
- 64
- Issue
- 7
- Pages
- 1411-1418
- ISSN
- 0028-3940 (ISSN-L)
- 1432-1920
- OpenAlex
- W4226146897
- Cited by
- 6
- References
- 36
- Citations by year
- 2025: 2 · 2024: 2 · 2023: 1 · 2022: 1
- FWCI
- 1.11
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Neuroradiology (publishedVersion)
- PubMed (publishedVersion)
- Dspace Repository (Marmara Üniversitesi) (submittedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pituitary Gland Disorders and Treatments
- Health Sciences › Medicine › Surgery › Adrenal and Paraganglionic Tumors
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Keywords
- inferior petrosal sinus sampling, prolactin measurement, ACTH-dependent hypercortisolism, Cushing's disease, ectopic ACTH syndrome, adrenal adenoma
- MeSH terms
- Adrenocorticotropic Hormone, Humans, Pituitary Neoplasms, Prolactin, Retrospective Studies, Petrosal Sinus Sampling, Pituitary ACTH Hypersecretion
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review